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We analyzed the whole genome sequence and resistome of the outbreak Klebsiella pneumoniae strain MP14 and compared
it with those of K. pneumoniae carbapenemase- (KPC-) producing isolates that showed high similarity in the NCBI genome
database. A KPC-2-producing multidrug-resistant (MDR) K. pneumoniae clinical isolate was obtained from a patient admitted to
a Korean hospital in 2011.The strainMP14 was resistant to all tested 𝛽-lactams including monobactam, amikacin, levofloxacin, and
cotrimoxazole, but susceptible to tigecycline and colistin. Resistome analysis showed the presence of 𝛽-lactamase genes including
𝑏𝑙𝑎KPC-2, 𝑏𝑙𝑎SHV-11, 𝑏𝑙𝑎TEM-169, and 𝑏𝑙𝑎OXA-9. MP14 also possessed aac(6󸀠-)Ib, aadA2, and aph(3󸀠-)Ia as aminoglycoside resistance-
encoding genes, mph(A) for macrolides, oqxA and oqxB for quinolone, catA1 for phenicol, sul1 for sulfonamide, and dfrA12 for
trimethoprim. Both SNP tree and cgMLST analysis showed the close relatedness with the KPC producers (KPNIH strains) isolated
from an outbreak in the USA and colistin-resistant strains isolated in Italy.The plasmid-scaffold genes in plasmids pKpQil, pKpQil-
IT, pKPN3, or pKPN-IT were identified in MP14, KPNIH, and Italian strains. The KPC-2-producing MDR K. pneumoniae ST258
stain isolated in Korea was highly clonally related with MDR K. pneumoniae strains from the USA and Italy. Global spread of
KPC-producing K. pneumoniae is a worrying phenomenon.
1. Introduction
Klebsiella pneumoniae carbapenemase- (KPC-) producing K.
pneumoniae has spread worldwide after the initial report
in the USA [1] and has become a serious problem in
nosocomial infections due to the associated high mortality,
which can be as high as 50% [2–4]. KPC-2 is one of the
most common carbapenemases in Enterobacteriaceae in the
USA. Multilocus sequence typing (MLST) sequence type
(ST) 258 is a common type among KPC-2-producing K.
pneumoniae in various parts of the world [5–8]. In Korea,
KPC-2-producing K. pneumoniae ST11 first was detected in
2010, and a second case of KPC-2-producing K. pneumoniae
ST258 was also reported [9]. Subsequently, an outbreak of
three cases of KPC-2-producing K. pneumoniae was detected
in a teaching hospital in Korea [10].
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Pulsed-field gel electrophoresis (PFGE) and MLST have
been widely used to understand bacterial dissemination.
However, to control the further spread of KPC-2-producing
K. pneumoniae, a better understanding of their mode of
transmission is required. With rapid technological advances,
whole genome sequencing (WGS) using a massive parallel
sequencer is now becoming a standard protocol in bacterial
typing.
Here, we analyzed the whole genome sequence and resis-
tome of the outbreak strainMP14 and compared it with those
of KPC-2-producing isolates in the NCBI genome database
(http://www.ncbi.nlm.nih.gov/genome) that showed high
similarity to obtain insight into their mode of transfer.
2. Materials and Methods
2.1. Bacterial Isolates and Antimicrobial Susceptibility Testing.
The strain MP14 was isolated from the sputum sample of
a 72-year-old man with pneumonia in a Korean hospital
in 2011. He had no recent travel history. The species was
identified by conventional methods and the VITEK 32 GN
system (bioMe´rieux, Marcy l’Etoile, France). Antimicrobial
susceptibility testing was performed using the VITEK II N211
system (bioMe´rieux).
2.2. Whole Genome Sequencing. Genome sequence of MP14
was obtained using a combination of Illumina Miseq (150 bp
paired end) and Roche 454 (0.8 kb insert paired end)
sequencing systems. A total of 3,445,050 paired reads were
obtained from Miseq run (Q30 > 78%), and 199,522 reads
were obtained from 454 sequencing systems. The sequences
obtained fromMiseq were assembled using the CLC genomic
workbench (CLC Bio, Denmark), and the sequences from
the 454 sequencing systems were assembled using GS De
Novo Assembler 2.3 (Roche Diagnostics, Branford, CT).
The length of minimum contig was 500 bp, and mismatch
cost (2), insertion cost (3), deletion cost (3), length fraction
(0.5), and similarity fraction (0.8) were used for assembly of
Illumina reads inCLCgenomicworkbench. For assembly 454
sequence reads, the length of minimum overlap was 40 bp,
and the identity of minimum overlap was 90%. Alignment
identity score (2) and alignment difference score (−3) were
used in GS De Novo Assembler. Hybrid assembly of strain
MP14 sequences from Miseq and 454 was conducted using
CodonCode Aligner (CodonCode Co., MA). The genes were
identified with Glimmer (maximum overlap length was 50,
minimum gene length was 110, and threshold score for
calling gene was 30) [11], and annotations were provided by
homology search against COGand SEEDdatabases (database
obtained at 2012-1-28) [12, 13]. The whole genomes of the
strains sequenced in this study were compared with the
reported genome sequences of K. pneumoniae isolates in the
NCBI genome database.
2.3. Identification of Resistomes and Plasmids. Antimicro-
bial resistance genes and plasmid types were analyzed
using ResFinder and PlasmidFinder, respectively, and using
resources from the Center for Genomic Epidemiology
(http://www.genomicepidemiology.org). ResFinder thresh-
old of ID = 98% and PlasmidFinder threshold of ID = 95%
were selected.
2.4. PFGE and Southern Blotting. Whole genomic DNA of
isolates was digested with S1 nuclease (Invitrogen, Abingdon,
UK) and PFGE was performed using a CHEF-DRII device
(Bio-Rad, Hercules, CA) as described previously [14]. Gels
with PFGE-separated fragments of DNA were blotted onto
nylon membranes (Bio-Rad) and hybridized with probes
specific for the 𝑏𝑙𝑎KPC-2 gene using the DIG DNA Labeling
and Detection Kit (Roche Diagnostics GmbH, Mannheim,
Germany).
2.5. SNP Tree and cgMLST Analysis. The single nucleotide
polymorphism (SNP) tree web server of the Center for
Genomic Epidemiology (http://cge.cbs.dtu.dk) was used to
generate SNPs tree.Theminimum coverage for SNP calls was
10, the minimum distance between SNPs (prune) was 10 bp,
and the minimum distance to the end of sequence from a
reference sequence end was 0 bp. Genome sequence of K.
pneumonia 342 (CP000964) was used as reference for SNP
calls.
A core genome MLST (cgMLST) scheme was defined
using the Ridom SeqSphere+ software (Ridom GmbH, Mun-
ster, Germany) with default settings [15]. The genome of
the K. pneumoniae KCTC2242 served as reference genome
and the following seven query genomes were used: K. pneu-
moniae (strains NC 018522.1, NC 011283.1, NC 022566.1,
NC 016845.1, NC 022082.1, NC 009648.1, and NC 012731.1).
Default settings included the removal of the shorter of two
genes overlapping by more than four bases and of genes with
an internal stop codon inmore than 80%of all query genomes
from the scheme [15].
3. Results
The strain MP14 was resistant to multiple antibiotics
including ampicillin (MIC, ≥32mg/L), ampicillin-sulbactam
(≥32mg/L), piperacillin-tazobactam (≥128mg/L), cefoxitin
(≥64mg/L), ceftazidime (≥64mg/L), cefotaxime (32mg/L),
cefepime (16mg/L), aztreonam (≥64mg/L), meropenem
(≥16mg/L), cotrimoxazole (≥32mg/L), amikacin (≥64mg/
L), and levofloxacin (≥8mg/L) butwas susceptible to gentam-
icin (≤1mg/L), tigecycline (2mg/L), and colistin (0.5mg/L).
A total of 186 contigs representing 5,661,622 bases
(56.98% G+C ratio, N50 = 156,843) were obtained from
hybrid assembled sequences of strain MP14 (183.76 × cov-
erage). 5,708 CDS, 4 rRNA genes, and 77 tRNA genes were
annotated for final contigs. A genome tree composed of
strain MP14 and 40 related strains obtained from the NCBI
database (date last accessed, 1 October 2013) was constructed
using the UPGMA dendrogram based on average identity
(ANI) value [16] computed by a BLAST algorithm (Figure 1).
Strains in the NCBI database similar toMP14 were as follows:
KPNIH strains from outbreak patients in the USA [17];
ST258-K28BO, ST512-K30BO, and ST258-K26BO isolated
frompatients in Italy [18]; andKPNV901664, a strain isolated
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Figure 1: A genome tree and resistome analysis of strain MP14 and similar strains obtained from the NCBI database. The genome tree (left)
was constructed using the UPGMA dendrogram based on average nucleotide identity values. The scale bar indicates the difference of ANI
values among strains. In resistome analysis (right), boxes show the presence (gray and red) or absence (white) of the relevant genes for each
of the isolates. Fos: fosfomycin; MLB: macrolide-lincosamide-streptogramin B; Rif: rifampicin.
4 BioMed Research International
Lhr
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
tnp1
ISKpn7 ISKpn6
tnpARecD ProQ ProQ IstAIstB tnpAtnpR tnpA KPC
Tn4401
Figure 2: Comparison of genes identified in contigs containing the 𝑏𝑙𝑎KPC gene in strain MP14 (d) and representative strains showing high
similarity: KPNIH14 (a), KPNIH19 (b), KPNIH23 (c), ST258-K28BO (e), ST512-K30BO (f), KPN V901664 (g), and ST258-K26BO (h).
KpQ3
1191100241
HS11286
ST512-K30BO
ST258-K26BO
ST258-K28BO
KPN V90166
KPNIH1
KPNIH14
KPNIH19
KPN MP14
KCTC2242
JH1
WGLW5
1084
NTUH-K2044
WGLW2
1162281
DSM30104T
LCT-KP214
WGLW1
WGLW3
MGH 78578
MSK. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
0.02
(a)
China HS11286
614
Italy ST258-K28BO
61
2208
USA KPNH1
Spain KpQ3
KPN MP14 USA KPNIH14
USA KPNIH19
USA KPN V901664
63 11
61
3
2554
USA WGLW1
2
USA WGLW3
197
China LCT-KP214
2783
2726
2735 2675
2708 Taiwan 1084
219
Taiwan NTUH-K2044
Korea DSM30104USA 1162281
USA WGLW5
101
USA JHI
USA WGLW2
(b)
Figure 3: SNP tree (a) and cgMLST analysis (b) using whole genome sequences of the strain MP14 and similar strains obtained from the
NCBI database.
in the early 2000s in the USA. The identity value between
MP14 and these strains was over 99.8% in ANI analysis.
All of those isolates carried 𝑏𝑙𝑎KPC-2 or 𝑏𝑙𝑎KPC-3 genes. All
of these isolates were MLST ST258 except for one (ST512-
K30BO). The K. pneumoniae HS11286 strain carrying the
𝑏𝑙𝑎KPC-2 gene from China was ST11. A length of the Tn4401
region harboring 𝑏𝑙𝑎KPC alleles was observed in some of the
compared strains including KPNIH strains 14, 19, and 23,
ST258-K28BO, ST512-K30BO, ST258-K26BO, and V901664
(Figure 2). Furthermore, the genetic environment around
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Figure 4: PFGE patterns of S1-digested DNA fragments (a) and
Southern blotting with the 𝑏𝑙𝑎KPC-2 probe (b). Lane M, lambda
ladder (Bio-Rad) as a DNA size marker; lane 1, a clinical isolate of
K. pneumoniae; lane 2, the strain MP14.
Tn4401 was highly similar among the compared strains,
suggesting the existence of a larger mobile element than
Tn4401 carrying the 𝑏𝑙𝑎KPC gene.
K. pneumoniaKPNMP14 was themost similar to KPNIH
strains than other strains in SNP tree (Figure 3). Strain MP
14 was clustered with Italy strains (ST258-K28BO, ST258-
K26BO, and ST512-K30BO) and USA strains. The result was
similar to genome tree.
A cgMLST scheme of K. pneumoniae was defined using
NCBI data in this study. Using K. pneumoniae KCTC 2422
strain as reference genome (4,923 genes) and the genome
of further seven K. pneumoniae strains as query genomes,
we defined the standard set of 3,548 genes for the cgMLST
scheme.
The resistomes of strain MP14 and other isolates are pre-
sented in Figure 1. The strain MP14 possessed the following
resistance genes: four 𝛽-lactamase genes 𝑏𝑙𝑎KPC-2, 𝑏𝑙𝑎SHV-11,
𝑏𝑙𝑎TEM-169 , and 𝑏𝑙𝑎OXA-9; aac(6󸀠)-Ib, aadA2, and aph(3󸀠)-Ia
as aminoglycoside resistance-encoding genes; mph(A) for
macrolides; oqxA and oqxB for quinolone; catA1 for phenicol;
sul1 for sulfonamide; and dfrA12 for trimethoprim. The
KPNIH series isolated in the USA and three Italian strains
had very similar resistomes to that of strain MP14.
We analyzed the WGS of the related strains using a web
tool, PlasmidFinder, for characterization of plasmids [19].
Plasmid-scaffold genes such as FII(K), FIB(K), FIB(pQil),
and ColRNAI were present in the strain MP14, in all iso-
lates of KPNIH strains compared, and in the three Italian
strains (Figure 1). FIB(K) is known to be associated with
plasmid pKPN3 identified in the USA (GenBank accession
number CP000648) and plasmid pKPN-IT identified in
Italy (JN233704)19. FII(K) and FIB(pQil) are plasmid-scaffold
regions of plasmids pKpQil and pKpQil-IT (NC 014016 and
JN233705, resp.), which are approximately 115 kb sized plas-
mids carrying the 𝑏𝑙𝑎KPC-3 gene [20]. Based on hybridization
of S1-digestedDNA fragments of the strainMP14, the 𝑏𝑙𝑎KPC-2
probe hybridized with an approximately 120 kb plasmid
(Figure 4).
4. Discussion
WGS was carried out for a KPC-2-producing K. pneumoniae
strain that was isolated in Korea in 2011. Genome sequences
of 24 KPC-2-producing K. pneumoniae strains (isolated in
USA and Italy) similar to Korean strain MP14 were obtained
from the NCBI database. Strain MP14 could be compared
among strains isolated in different countries or at different
times by whole genome sequences and various information
of strain could be analyzed. The strain MP14 carried several
antimicrobial resistance genes for different antibiotic classes
and showed multidrug resistance as expected.
The cgMLST scheme in K. pneumoniae isolate was con-
structed in this study, for the first time. The cgMLST results
were comparable to those of the SNPs tree in K. pneumoniae
isolates (Figure 3). The cgMLST may be a promising tool
for standardized, portable, and expandable approach in K.
pneumoniae isolates although this study has a limitation
stemming from its small sample size.
Both SNP and cgMLST based whole genome sequences
supported the closer relatedness MP14 strain, KPN NIH
strains, and Italy ST strains carrying 𝑏𝑙𝑎KPC genes. These
suggested that the transmission of KPC-producing K. pneu-
moniae did not happen by mobile genetic elements but
by spread of clone. Although we could not obtain the full
sequence of the 𝑏𝑙𝑎KPC-2 gene-associated plasmids in the
MP14 strain, this strain was found to possess several plasmid-
scaffold genes that were previously reported in plasmids
pKpQil from Israel and pKpQil-IT from Italy, which carried
the 𝑏𝑙𝑎KPC-2 genes pKPN3 from the USA and pKPN-IT from
Italy.These findings suggest transfer of plasmids carrying the
𝑏𝑙𝑎KPC gene together with the host strains from the USA or
Italy to Korea.
5. Conclusion
Whole genome sequencing and its in-depth analysis of the
KPC-2-producing MDR K. pneumoniae ST258 strain from
Korea made it evident that this was strongly related to
MDR K. pneumoniae strains from USA and Italy. Global
spread of KPC-producing K. pneumoniae is a worrying
phenomenon and close inspection to stop their spread is
strongly warranted.
Consider nucleotide sequence accession numbers: the
nucleotide sequence data reported in this paper are available
in the DDBJ/EMBL/GenBank nucleotide database under
accession number ATAK00000000.
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